PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection

BACKGROUND: The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in low-density lipoprotein receptor homeostasis, with potential influence on vascular inflammation and on COVID-19 inflammatory response. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarese, Eliano P., Podhajski, Przemysław, Gurbel, Paul A., Grzelakowska, Klaudyna, Ruscio, Eleonora, Tantry, Udaya, Magielski, Przemysław, Kubica, Aldona, Niezgoda, Piotr, Adamski, Piotr, Junik, Roman, Przybylski, Grzegorz, Pilaczyńska-Cemel, Marta, Rupji, Manali, Specchia, Giuseppe, Pinkas, Jarosław, Gajda, Robert, Gorog, Diana A., Andreotti, Felicita, Kubica, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842071/
https://www.ncbi.nlm.nih.gov/pubmed/36653090
http://dx.doi.org/10.1016/j.jacc.2022.10.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842071/
https://www.ncbi.nlm.nih.gov/pubmed/36653090
http://dx.doi.org/10.1016/j.jacc.2022.10.030

Ejemplares similares